Chronic Kidney Disease

Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease

By NewsOnFloor 04 May 2023

Advertisment

Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022

Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients Therapy recen

By NewsOnFloor 30 Apr 2023

Share LinkedIn

Business

Fresenius Medical Care partners with National Kidney Foundation Malaysia in kidney health initiative

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today signed a memorandum of understanding (MoU) with the National Kidney Foundation

By NewsOnFloor 29 Apr 2023

Share LinkedIn

Business

NATHEALTH 9th Annual Summit 2023: Healthcare Leaders Call for Addressing Current Barriers and Unlocking Critical Pathways to Achieving Universal Health Coverage

Healthcare industry expects exponential rise in digital health adoption Healthcare providers call for boosting infrastructure to address ESRD Healthcare leaders highlight need to make insurance access

By NewsOnFloor 26 Apr 2023

Share LinkedIn

Web Stories